Similarly, the two-gene panel of SOX1 + HOXA9 was found positive for methylation in 80.0% (8/10) of stage I/II, 56.7% (17/30) of stage III, and 80.0% (4/5) of stage IV ovarian cancers (Table 3). This evidence concerns the gene SOX1 and ovarian carcinoma.